Skip to content 
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions, as well as detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body at extremely low concentrations through clinical laboratories and in point-of-care settings, including physicians' offices and over-the-counter channels. It also provides contract development and manufacturing services to third parties. In addition, the company commercializes inFoods IBS product through physician-directed and laboratory-based channels, such as third-party reimbursement pathways. Further, it is involved in the development and optimization of immunoassays, enzyme-linked immunosorbent assays, rapid diagnostic tests, and related diagnostic technologies; and research, development, commercialization of diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. Additionally, the company offers EZ detect colon disease home test; Aware Breast Self-Exam product; and hp+detect, a diagnostic test designed to detect Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. more
| Time Frame | BMRA | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -6.9% | -2.64% | -1.19% |
| 1-Month Return | -1.82% | -3.9% | -0.15% |
| 3-Month Return | 23.43% | 1.5% | 2.56% |
| 6-Month Return | -0.46% | 13.21% | 16.48% |
| 1-Year Return | -21.74% | 16.07% | 14.16% |
| 3-Year Return | -67.82% | 29.28% | 78.87% |
| 5-Year Return | -95.2% | 32.55% | 78.17% |
| 10-Year Return | -90.62% | 130.67% | 254.61% |
| May '22 | May '23 | May '24 | May '25 | May '26 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 18.87M | 5.34M | 5.42M | 5.31M | 4.45M | [{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":28.29,"profit":true},{"date":"2024-05-31","value":28.69,"profit":true},{"date":"2025-05-31","value":28.14,"profit":true},{"date":"2026-05-31","value":23.6,"profit":true}] |
| Cost of Revenue | 15.89M | 4.89M | 4.80M | 4.81M | 4.09M | [{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":30.79,"profit":true},{"date":"2024-05-31","value":30.23,"profit":true},{"date":"2025-05-31","value":30.28,"profit":true},{"date":"2026-05-31","value":25.74,"profit":true}] |
| Gross Profit | 2.98M | 446.00K | 611.00K | 498.00K | 362.00K | [{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":14.98,"profit":true},{"date":"2024-05-31","value":20.52,"profit":true},{"date":"2025-05-31","value":16.73,"profit":true},{"date":"2026-05-31","value":12.16,"profit":true}] |
| Gross Margin | 15.78% | 8.35% | 11.28% | 9.38% | 8.13% | [{"date":"2022-05-31","value":100,"profit":true},{"date":"2023-05-31","value":52.95,"profit":true},{"date":"2024-05-31","value":71.52,"profit":true},{"date":"2025-05-31","value":59.43,"profit":true},{"date":"2026-05-31","value":51.53,"profit":true}] |
| Operating Expenses | 7.51M | 7.67M | 6.98M | 5.63M | 5.68M | [{"date":"2022-05-31","value":97.94,"profit":true},{"date":"2023-05-31","value":100,"profit":true},{"date":"2024-05-31","value":90.99,"profit":true},{"date":"2025-05-31","value":73.48,"profit":true},{"date":"2026-05-31","value":74.09,"profit":true}] |
| Operating Income | (4.53M) | (7.22M) | (6.37M) | (5.14M) | (5.32M) | [{"date":"2022-05-31","value":-453396400,"profit":false},{"date":"2023-05-31","value":-722300000,"profit":false},{"date":"2024-05-31","value":-636700000,"profit":false},{"date":"2025-05-31","value":-513700000,"profit":false},{"date":"2026-05-31","value":-532000000,"profit":false}] |
| Total Non-Operating Income/Expense | 53.64K | 267.00K | 862.00K | 330.00K | 2.80M | [{"date":"2022-05-31","value":1.91,"profit":true},{"date":"2023-05-31","value":9.53,"profit":true},{"date":"2024-05-31","value":30.77,"profit":true},{"date":"2025-05-31","value":11.78,"profit":true},{"date":"2026-05-31","value":100,"profit":true}] |
| Pre-Tax Income | (4.51M) | (7.09M) | (5.94M) | (4.97M) | (3.75M) | [{"date":"2022-05-31","value":-450732500,"profit":false},{"date":"2023-05-31","value":-708900000,"profit":false},{"date":"2024-05-31","value":-593600000,"profit":false},{"date":"2025-05-31","value":-497200000,"profit":false},{"date":"2026-05-31","value":-375200000,"profit":false}] |
| Income Taxes | 23.72K | 51.00K | 42.00K | 1.00K | 23.00K | [{"date":"2022-05-31","value":46.51,"profit":true},{"date":"2023-05-31","value":100,"profit":true},{"date":"2024-05-31","value":82.35,"profit":true},{"date":"2025-05-31","value":1.96,"profit":true},{"date":"2026-05-31","value":45.1,"profit":true}] |
| Income After Taxes | (4.53M) | (7.14M) | (5.98M) | (4.97M) | (3.77M) | [{"date":"2022-05-31","value":-453104400,"profit":false},{"date":"2023-05-31","value":-714000000,"profit":false},{"date":"2024-05-31","value":-597800000,"profit":false},{"date":"2025-05-31","value":-497300000,"profit":false},{"date":"2026-05-31","value":-377500000,"profit":false}] |
| Income From Continuous Operations | (4.53M) | (7.14M) | (5.98M) | (4.97M) | (3.77M) | [{"date":"2022-05-31","value":-453104400,"profit":false},{"date":"2023-05-31","value":-714000000,"profit":false},{"date":"2024-05-31","value":-597800000,"profit":false},{"date":"2025-05-31","value":-497300000,"profit":false},{"date":"2026-05-31","value":-377500000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2022-05-31","value":"-","profit":true},{"date":"2023-05-31","value":"-","profit":true},{"date":"2024-05-31","value":"-","profit":true},{"date":"2025-05-31","value":"-","profit":true},{"date":"2026-05-31","value":"-","profit":true}] |
| Net Income | (4.53M) | (7.14M) | (5.98M) | (4.97M) | (3.77M) | [{"date":"2022-05-31","value":-453104400,"profit":false},{"date":"2023-05-31","value":-714000000,"profit":false},{"date":"2024-05-31","value":-597800000,"profit":false},{"date":"2025-05-31","value":-497300000,"profit":false},{"date":"2026-05-31","value":-377500000,"profit":false}] |
| EPS (Diluted) | (0.36) | (0.50) | (0.36) | (2.16) | (1.30) | [{"date":"2022-05-31","value":-36,"profit":false},{"date":"2023-05-31","value":-50,"profit":false},{"date":"2024-05-31","value":-36,"profit":false},{"date":"2025-05-31","value":-216,"profit":false},{"date":"2026-05-31","value":-130,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| BMRA | |
|---|---|
| Cash Ratio | 0.53 |
| Current Ratio | 1.62 |
| Quick Ratio | 0.93 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| BMRA | |
|---|---|
| ROA (LTM) | -55.85% |
| ROE (LTM) | -97.19% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| BMRA | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.61 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.39 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| BMRA | |
|---|---|
| Trailing PE | NM |
| Forward PE | 0.30 |
| P/S (TTM) | 1.55 |
| P/B | 2.60 |
| Price/FCF | NM |
| EV/R | 1.68 |
| EV/Ebitda | NM |
| PEG | NM |
Biomerica Inc (BMRA) share price today is $2.142
Yes, Indians can buy shares of Biomerica Inc (BMRA) on Vested. To buy
Yes, you can purchase fractional shares of Biomerica Inc (BMRA) via the Vested app. You can start investing in Biomerica Inc (BMRA) with a minimum investment of $1.
You can invest in shares of Biomerica Inc (BMRA) via Vested in three simple steps:
The 52-week high price of Biomerica Inc (BMRA) is $3.21. The 52-week low price of Biomerica Inc (BMRA) is $1.45.
The price-to-earnings (P/E) ratio of Biomerica Inc (BMRA) is
The price-to-book (P/B) ratio of Biomerica Inc (BMRA) is 2.60
The dividend yield of Biomerica Inc (BMRA) is 0.00%
The market capitalization of Biomerica Inc (BMRA) is $10.28M
The stock symbol (or ticker) of Biomerica Inc is BMRA
Consider the share price of Biomerica Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biomerica Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Biomerica Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biomerica Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Biomerica Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biomerica Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
